Evidence map›Paper›PMID 30600673›Full record

ArticleGut and liver2019

Linyan Zhou, Dongyan Liu, Ying Xie, Xinjie Yao, Yan Li

Open access · diamondAbstract read
In one paragraph

Article in Gut and liver, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Frontiers in immunology · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Natural Ingredients to Improve Immunity.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Microbiome research reports · 2023
    Review
  13. Allergy, asthma & immunology research · 2022
    Article
  14. World journal of gastroenterology · 2022
    Article
  15. Review
  16. Frontiers in immunology · 2022
    Article
  17. The Metabolites ofFrontiers in microbiology · 2022
    Article
  18. Article
  19. Review
  20. Intestinal Regulatory T Cells.Advances in experimental medicine and biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Linyan ZhouDepartment of Gastroenterology, Shengjing Hospital Affiliated to China Medical University, Shenyang, China.ORCID http://orcid.org/0000-0002-9403-2809
Dongyan LiuMedical Research Center, Shengjing Hospital of China Medical University, Benxi, China.ORCID http://orcid.org/0000-0002-3902-9316
Ying XieDepartment of Gastroenterology, Shengjing Hospital Affiliated to China Medical University, Shenyang, China.ORCID http://orcid.org/0000-0001-8226-4242
Xinjie YaoDepartment of Gastroenterology, Shengjing Hospital Affiliated to China Medical University, Shenyang, China.ORCID http://orcid.org/0000-0003-0658-7773
Yan LiDepartment of Gastroenterology, Shengjing Hospital Affiliated to China Medical University, Shenyang, China.ORCID http://orcid.org/0000-0002-5155-6290
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aims: The current study aims to investigate the protective effects of Methods: Eight-week-old BALB/c mice were separated into five groups at random (control, DSS, DSS+B9 [ Results: Conclusions: In a mouse model of IBD,

Indexed as

Bifidobacterium longum subspecies infantisProbioticsAnimalsB7-H1 AntigenColitisDextran SulfateForkhead Transcription FactorsInflammatory Bowel DiseasesInterleukin-10MiceProgrammed Cell Death 1 ReceptorT-Lymphocytes, RegulatoryTransforming Growth Factor beta1B7-H1 AntigenCd274 protein, mouseDextran SulfateForkhead Transcription FactorsFoxp3 protein, mouseIL10 protein, mouseInterleukin-10Pdcd1 protein, mouseProgrammed Cell Death 1 ReceptorTgfb1 protein, mouseTransforming Growth Factor beta1Bifidobacterium infantisInflammatory bowel diseaseProgrammed cell death ligand 1regulatoryT-Lymphocytes

Identifiers

PMID30600673
PMCPMC6622561
OpenAlexW2907747129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.